PEPT (Regenerex Pharma) EV-to-FCF : 0.00 (As of Sep. 21, 2024)

Regenerex Pharma EV-to-FCF Chart

Regenerex Pharma Annual Data
	Trend	Nov10	Nov11	Nov12	Nov13	Nov14	Mar17	Mar18	Mar22	Mar23	Mar24
EV-to-FCF		Get a 7-Day Free Trial					-	-	-	-	-

Regenerex Pharma Quarterly Data
	Nov14	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
EV-to-FCF	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Regenerex Pharma's EV-to-FCF

For the Medical Instruments & Supplies subindustry, Regenerex Pharma's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Regenerex Pharma's EV-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Regenerex Pharma's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Regenerex Pharma's EV-to-FCF falls into.

Regenerex Pharma EV-to-FCF Calculation

Regenerex Pharma's EV-to-FCF for today is calculated as:

Regenerex Pharma's current Enterprise Value is $0.00 Mil.
Regenerex Pharma's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.39 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Regenerex Pharma  (OTCPK:PEPT) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Regenerex Pharma's PE Ratio for today is calculated as:

Regenerex Pharma's share price for today is $0.00.
Regenerex Pharma's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Regenerex Pharma EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Regenerex Pharma's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.

Regenerex Pharma Business Description